Notice of Amendment: Revision of Brimonidine on the Prescription Drug List (PDL) (English, HTML)

Notice of Amendment: Revision of Brimonidine on the Prescription Drug List (PDL): English HTML file. From Health Canada, updated Oct 2023. View metadata, licence and the direct download on CanQuery.

Format
HTML
Access
Original download only
Publisher-reported update
2023-10-29

The purpose of this Notice of Amendment is to notify that Health Canada has revised the listing of "brimonidine or its salts" on the Prescription Drug List (PDL). Note that both the human and veterinary parts of the PDL were revised with the addition of a qualifier.

Access original file

Data overview

Formats
HTML
File languages
English
Available actions
Access original file

Official sources and licences

Related open data